英国和美国今年准备对一种新型注射用抗癌疗法进行临床试验。新法是把单克隆抗体(monoclonal antibody)吸附于强力毒素内注射,该抗体在人体内能特异性地寻找到癌细胞,使毒素沉着于癌细胞内。德克萨斯州大学微生物部的Vitetta教授声称,此项研究使肿瘤的治疗进入新的年代。他说将致力于“用不同的抗体和毒素杀伤所有的瘤细胞,并预防其复 The United Kingdom and the United States are preparing clinical trials for a new type of anti-cancer therapy for injections this year. The new method is the adsorption of monoclonal antibodies (monoclonal antibodies) into powerful toxins. The antibodies can specifically find cancer cells in the human body, so that the toxins calm in the cancer cells. Professor Vitetta, from the Department of Microbiology at the University of Texas, claimed that this study has brought cancer treatment to a new era. He said that he will work on “killing all tumor cells with different antibodies and toxins and preventing their recovery.”